The focus of medicine lies not only in searching for viable treatments and cures for existing ailments but also in the prevention of disease. Vaccination induces immunity after an antigen is introduced to the body. This antigen usually consists of a live attenuated organism, an inactivated organism, a toxoid, or parts of an organism (acellular and subunit). The antigen is incapable of resulting in the full-blown manifestation of the disease, but it is potent enough to generate the formation of antibodies to protect against future illness. Traditionally, vaccination has been used to combat the spread of infectious diseases, such as cholera, rabies, polio, measles, and hepatitis. And this is still the case.
Medication safety has always been an important issue, but the Institute of Medicine's (IOM) recent report showing that preventable medication errors injure at least 1.5 million Americans annually illustrates the seriousness of this predicament. The authors of the IOM report, Preventing Medication Errors: The Quality Chasm Series, even acknowledge that this is likely a conservative assessment of drug safety gaps. The report noted that each year 530,000 preventable adverse drug events-injuries due to medication-affect outpatient Medicare patients, 380,000 to 450,000 occur in hospitals, and another 800,000 in long-term care facilities.
The FDA recommends that you counsel patients on the importance of reading product labels carefully to determine the active ingredients and dosing instructions of each product and to discourage them from making assumptions about use based on product names or appearance. The use of similar trade names (so-called "brand-name families") is common practice for OTC products. The products with the trade names "Sudafed" and "Sudafed PE" illustrate specific concerns.
Q Will there be a pharmacy shortage 25 years from now? How will the role of the pharmacist change?
This hasn't been a banner year for the Food & Drug Administration as guardian of our health and safety, for a storm of controversy has been following the agency like the black cloud that hovered over the head of cartoon character Mr. Mxyzptlk.
Managing the overall risk of medication therapy is more effective than simply managing drug-drug interactions.
Seniors prescribed multiple courses of antibiotics were at greater risk for IBD.
Popular contributor "Goose" Rawlings offers a simple solution to a universal problem.
The American Society of Health-System Pharmacists (ASHP) is providing quality improvement strategies for pharmacy practice settings across the continuum of care.
Drug Topics’ legal compliance columnist named partner in Roetzel's Chicago office and head of the firm’s Drug and Pharmacy practice.
Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.
Sandoz has announced the U.S. launch of an authorized generic version of PharmaDerm’s Solaraze Gel (diclofenac 3% gel), which generated $92 million in 2012.
This new treatment option copackages 3 drugs for optimal treatment.
Healthcare execs need to lay the cultural foundation today for upcoming technology changes
Fezolinetant (Veozah) is approved for the treatment of moderate to severe vasomotor symptoms (ie, hot flashes and night sweats) related to menopause.
Reevaluation of RECORD trial data fails to uncover elevated cardiovascular risk.
When it comes to knowledge of medications and their actions, pharmacists have it way over most physicians. For the sake of the patient, you have to speak up, whether the doc likes it or not.
Asking whether hydrocodone should be rescheduled is only the beginning.
If your inner entrepreneur is hollering to get out, maybe you should go for it.
The legalization of marijuana has consequences.
The action taken by CVS staffers seems to be the only way to get the attention of corporate officials.
Specialty pharmaceuticals will have a growing impact on pharmacists. Here’s how it could change your role.
Your patients are using herbal products, but do you know enough about them?
How can an independent pharmacy survive in the face of competition from the mega-chains? Here's a clue.
This year may mark a dramatic difference in the development and approval of complex generic drug products.
FDA approves apalutamide for castration-resistant prostate cancer.
FDA approves apalutamide for castration-resistant prostate cancer.